Cluster headache runs in families more often than you would expect by chance, but calling it simply “hereditary” overstates what the science has nailed down so far. About one in twelve people with cluster headache has a relative who also gets the attacks, and first-degree relatives face a dramatically higher risk than the general population. Yet twin studies show surprisingly low concordance, and genome-wide searches have turned up only a handful of gene variants, none of which come close to explaining the full picture. The honest answer is that genetics loads the gun while environment and biology pull the trigger, and researchers are still sorting out exactly which genes and which triggers matter most.
How Often Cluster Headache Runs in Families
The most comprehensive look at this question comes from a systematic review that pooled 22 large cohort studies. Across those studies, the share of cluster headache patients who reported at least one affected family member ranged from zero to about a fifth, with a median around 8%.1PubMed Central. Family History of Cluster Headache: A Systematic Review That might sound modest, but cluster headache itself is rare, affecting roughly one in 500 people. When a condition is that uncommon, even an 8% family-history rate signals something genetic is going on.
The relative-risk numbers tell the story more sharply. A study of 220 Danish families found a positive family history in about a fifth of them. First-degree relatives of those patients had a roughly 39-fold increased risk compared with the general population.2PubMed. Increased familial risk of cluster headache An earlier study of 370 patients in Italy reported a 14-fold increased risk in first-degree relatives and about a twofold increase in second-degree relatives.3PubMed Central. Familial occurrence of cluster headache That spread, from 14-fold to 39-fold, is wide enough to suggest the true number depends heavily on which population you study and how you recruit. But even the lower estimate is striking: it means if your parent or sibling gets cluster headaches, your own risk is many times higher than normal.
What Twin Studies Show, and What They Do Not
Twin studies are usually the gold standard for separating genetic influence from shared environment, because identical twins share all their DNA while fraternal twins share roughly half. For cluster headache, the twin data is surprisingly thin. The largest study, in the Swedish twin registry, found that among 12 pairs of identical twins where one twin had cluster headache, only two co-twins also had it. Among 25 pairs of fraternal twins, none of the co-twins were affected.4PubMed. Lifetime prevalence and concordance risk of cluster headache in the Swedish twin population On its face, that looks like a weak genetic signal: most identical twins of cluster headache patients never develop it themselves.
But this is where sample size matters. Cluster headache is rare enough that even a national twin registry turns up only a few dozen relevant pairs. With numbers that small, concordance rates bounce around wildly. The fact that identical twins showed any concordance at all while fraternal twins showed none is at least consistent with a genetic contribution. Researchers have interpreted the twin data cautiously: genetics plays some role in familial clustering, but the condition is clearly not determined by genes alone.
How It Might Be Inherited
If cluster headache does have a genetic component, what kind of inheritance pattern does it follow? A formal segregation analysis of cluster headache families suggested that in some families, the condition behaves like an autosomal dominant trait with very low penetrance, meaning the gene is passed through families in a straightforward way but only “activates” in a fraction of the people who carry it. The estimated penetrance was around 30–34% in men and 17–21% in women.5PubMed. Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis That low penetrance helps explain why the condition can skip generations and why most relatives of affected people never develop it.
The same systematic review that calculated the 8.2% family-history median also examined 67 published family trees. About two-thirds of those pedigrees were consistent with a dominant inheritance pattern, while roughly a quarter looked more like recessive inheritance. The takeaway is that there is probably no single mode of inheritance for all cluster headache. Some families carry a dominant variant with low penetrance; other families may have a recessive pattern; and most cases appear sporadic, with no obvious family link at all.
Genome-Wide Searches for Risk Genes
Over the past few years, large-scale genome scans have started to identify specific stretches of DNA linked to cluster headache risk. One major genome-wide association study found four independent genetic loci reaching strong statistical significance, near genes including MERTK and FHL5. Together, those four loci explained about 7% of the total variance in who gets the condition, which is a meaningful slice but leaves most of the picture unexplained.6PubMed Central. Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache
A second genome-wide study, run independently, identified additional risk loci on chromosomes 1, 2, and 6. One of those loci overlaps with a region already known to increase risk for migraine, raising interesting questions about shared biology between the two conditions. This study’s downstream analyses also pointed to immune-system pathways as part of the disease mechanism.7PubMed Central. Genome-Wide Association Study Identifies Risk Loci for Cluster Headache A later meta-analysis extended the tally to eight loci total and, through genetic modeling, offered evidence that smoking intensity acts as a causal risk factor, not just a correlate.8PubMed. Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor
What these studies collectively show is that cluster headache is genetically complex. There is no single “cluster headache gene.” Instead, multiple common gene variants each nudge risk a small amount. That 7% of explained variance is typical for complex disorders at an early stage of genetic research; migraine’s known loci explain a similarly modest fraction of its heritability. More variants will probably be discovered as sample sizes grow.
The Orexin Receptor Gene
Before the genome-wide era, researchers zeroed in on candidate genes they suspected might be involved based on what was known about cluster headache biology. The most studied of these is HCRTR2, the gene encoding the receptor for orexin (also called hypocretin), a brain chemical involved in sleep-wake regulation. Cluster headache attacks famously follow a circadian pattern and often strike during sleep, making the orexin system a logical suspect.
A German study found that people homozygous for a particular variant of HCRTR2 had roughly twice the risk of cluster headache compared to those without it.9PubMed. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene A meta-analysis pooling multiple studies confirmed that carrying this variant modestly increased risk.10PubMed Central. Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis However, a Swedish study looking at a broader set of HCRTR2 variants found that the association did not hold after correcting for multiple comparisons.11PubMed Central. Analysis of HCRTR2 Gene Variants and Cluster Headache in Sweden This is a familiar pattern in genetics: an early exciting finding that partially replicates but does not hold up universally. The orexin pathway likely plays some role, but HCRTR2 is not the major driver it was once hoped to be.
Circadian Clock Genes
The clockwork timing of cluster headache has always been one of its most distinctive features. Attacks tend to strike at the same time each day, often in the early morning hours, and bouts recur seasonally. That regularity points squarely at the body’s internal clock, which is governed by a set of core “clock genes” including CLOCK, PER, and REV-ERBα.
A systematic review and genetic analysis found that cluster headache was associated with variations in the CLOCK and REV-ERBα genes. Strikingly, five of the nine genomic regions identified in cluster headache susceptibility studies turned out to be regulated by the circadian system.12PubMed Central. Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis A separate study drilled deeper into one CLOCK gene variant, rs12649507, and found it was significantly associated with cluster headache, especially among patients who reported strong day-night rhythmicity in their attacks. The same variant was linked to higher expression of CLOCK protein in laboratory cell cultures.13PubMed. A genetic CLOCK variant associated with cluster headache causing increased mRNA levels
This is one of the more satisfying threads in cluster headache genetics, because it connects a clinical hallmark (clocklike timing) to a plausible biological mechanism (altered circadian gene expression). It does not explain why attacks are painful, but it helps explain why they are so predictable.
Nitric Oxide and Other Candidate Pathways
Nitric oxide is a signaling molecule involved in blood-vessel dilation and pain transmission, both of which are relevant to cluster headache. Researchers have looked at genetic variants in the three enzymes that produce nitric oxide, but results have been mostly disappointing. An early Swedish study found no meaningful differences in these gene variants between patients and controls.14PubMed. Analysis of nitric oxide synthase genes in cluster headache A later, larger Swedish analysis found a weak association with one particular combination of variants in the inducible nitric oxide synthase gene, but the effect was modest enough that the authors themselves concluded NOS genes do not have a strong influence on cluster headache susceptibility.15PubMed Central. Analysis of NOS Gene Polymorphisms in Relation to Cluster Headache and Predisposing Factors in Sweden
This is the frustrating reality of candidate-gene research across many diseases. Most biologically plausible candidates either fail to replicate or turn out to have effects too small to matter on their own. The genome-wide approach has proven more productive, precisely because it does not rely on educated guesses about which genes should be involved.
Smoking, Heavy Metals, and Gene-Environment Interaction
Cluster headache patients smoke at noticeably higher rates than the general population. For years, the debate was whether smoking was a genuine risk factor or just a correlate driven by personality or lifestyle. The genetic evidence has started to settle the question. The genome-wide meta-analysis that identified eight risk loci also used a technique called Mendelian randomization to test whether smoking has a causal effect. The method leverages the fact that gene variants influencing how much someone smokes are randomly distributed in the population. That analysis indicated that smoking intensity causally raises cluster headache risk.8PubMed. Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor
A more recent study went further, examining whether heavy-metal exposure from cigarette smoke might be part of the mechanism. That study found indirect evidence that heavy metals were elevated in cluster headache patients and that global DNA methylation patterns, which are one way the environment changes how genes are read, tended to be altered as well.16PubMed. Increased markers of heavy metal exposure and DNA methylation in cluster headache If confirmed, this would mean smoking does not just trigger attacks in a genetically susceptible person but may actually change the way their genes are expressed, creating a deeper gene-environment loop.
How Familial Cases Differ from Sporadic Ones
You might assume that all cluster headache looks the same regardless of whether it runs in a family. It mostly does, but some interesting differences have emerged. A study comparing familial and sporadic cases found that patients with a family history were more likely to report nasal blockage during attacks and had higher rates of a co-occurring condition called short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT).17PubMed Central. The clinical characteristics of familial cluster headache Separately, a positive family history was more common among people with chronic cluster headache (attacks year-round without a remission period) than among those with the episodic form. Those familial cases also had a distinctive pattern of attacks, with twice the risk of nocturnal episodes.18PubMed. Episodic and Chronic Cluster Headache: Differences in Family History, Traumatic Head Injury, and Chronorisk
Research on Swedish families also noted that among relatives of cluster headache patients, a sizeable number had headache that resembled cluster headache but did not meet the formal diagnostic criteria. The authors suggested that “atypical” cluster headache in these families may represent a broader spectrum of the same underlying condition, driven by the same genetic background but expressing itself in a milder or less classic way.19PubMed. Familial cluster headache. Is atypical cluster headache in family members part of the clinical spectrum? If true, the real family-history rate could be higher than the numbers suggest, because some affected relatives are being missed by strict diagnostic criteria.
Sex Differences in Who Gets Cluster Headache
Cluster headache has historically been described as a condition that overwhelmingly affects men, with ratios as high as six to one cited in older literature. More recent studies have narrowed that gap, but men still predominate. Genetics cannot fully explain this sex ratio on its own, because autosomal genes are shared equally between the sexes. The segregation analyses that found low-penetrance dominant inheritance also found that the gene’s penetrance was roughly half as high in women as in men, suggesting something about female biology partially suppresses the trait even when the relevant gene variant is present.20PubMed. Cluster headache is an inherited disorder in some families
Hormones are one plausible explanation. A study of women with cluster headache found that disease onset frequently corresponded with major hormonal transitions: the start of menstruation, the post-partum period, or menopause.21PubMed Central. Gender Differences in the Clinical Presentation of Cluster Headache: A Role for Sexual Hormones? This does not mean hormones cause cluster headache directly, but it hints that fluctuating sex hormones interact with whatever genetic susceptibility exists to influence when and whether the disease appears.
What This Means if Cluster Headache Runs in Your Family
Given all this evidence, a practical question is whether you should worry if a close relative has cluster headache. The relative risk is genuinely elevated, but absolute risk remains low. Cluster headache affects roughly one in 500 people. Even a 14-fold increase from that baseline means the absolute probability is still only a few percent. A 39-fold increase raises it higher, but you are still far more likely not to develop the condition than to develop it.
There is currently no clinical genetic test for cluster headache, and none is likely to arrive soon. The known risk variants each contribute a tiny fraction of the overall risk, and the gene-environment interactions make prediction from DNA alone unrealistic. If you have a family history, the most practical step is awareness: knowing what cluster headache looks like so you can seek diagnosis early if you ever develop severe, unilateral headache attacks with clocklike regularity. Early diagnosis matters because effective treatments exist, including high-flow oxygen, triptans for acute attacks, and preventive medications, but many patients endure years of misdiagnosis before getting the right treatment.
The Trigeminovascular System and CGRP
The genetics of cluster headache eventually converge on the brain’s pain-processing hardware. During an attack, the trigeminal nerve fires and releases calcitonin gene-related peptide (CGRP), a powerful vasodilator. Elevated CGRP levels have been measured in the blood draining from the affected side of the head during active bouts, and infusing CGRP into a patient in an active phase can trigger an attack.22PubMed Central. Calcitonin Gene-Related Peptide (CGRP) and Cluster Headache Interestingly, a more recent study found that baseline CGRP levels were actually reduced in cluster headache patients, suggesting the peptide’s role is more complex than a simple “more CGRP, more pain” model.23PubMed. Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study This complexity is relevant to the genetics question because CGRP-targeting drugs, already approved for migraine, are being explored for cluster headache, and understanding how genetic variation affects the CGRP pathway could eventually help predict who responds to these treatments.
Where Genetics May Lead Treatment
One of the most promising applications of genetic knowledge in cluster headache is the hunt for new drug targets. A recent proteome-wide analysis used genetic tools to identify 11 circulating proteins whose levels are causally linked to cluster headache risk. Among these, five novel targets showed no significant disease-related side effects and interacted with the molecular targets of drugs already used for prevention.24PubMed Central. Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis The same analysis found that part of the effect of these proteins on cluster headache risk was mediated through changes in the brain’s cortical surface area, linking genetics to brain structure in a measurable way. None of these potential targets has reached clinical trials yet, but the approach illustrates how genetic data can shortcut the drug-discovery process by pointing researchers toward proteins that are both causally involved and safely targetable.
Variation Across Populations
Most of the genetic research on cluster headache has been conducted in European populations, which creates a real blind spot. A global review noted that attack characteristics, bout patterns, and circadian rhythmicity vary among different ethnic groups.25PubMed. Epidemiology, burden and clinical spectrum of cluster headache: a global update Whether those differences reflect distinct genetic backgrounds, different environmental exposures, or differences in diagnosis and reporting is not yet clear. What is clear is that the gene variants identified so far may not carry the same risk in non-European populations. Until genome-wide studies include more diverse cohorts, the heritability estimates and specific risk loci should be treated as preliminary findings from one slice of humanity rather than universal truths.